Koyfin Home > Directory > Health Care > Incyte Corp > EBITDA

Incyte Corp EBITDA Chart (INCY)

Incyte Corp annual/quarterly EBITDA from 1993 to 2018. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Incyte Corp EBITDA for the quarter ending December 12, 2018 was $103m a 145.94% increase of 150m year over year
  • Incyte Corp EBITDA for the last 12 months ending December 12, 2018 was $209m a 152.41% increase of 318m year over year
  • Incyte Corp Annual EBITDA for 2018 was $209m a 185.34% increase of 386m from 2017
  • Incyte Corp Annual EBITDA for 2017 was $-178m a 207.25% decrease of -369m from 2016
  • Incyte Corp Annual EBITDA for 2016 was $191m a 67.65% increase of 129m from 2015
Other Income Statement Metrics:
  • Incyte Corp Net Income for the quarter ending December 12, 2018 was $69m a 159.57% increase of 110m year over year
  • Incyte Corp Total Revenue for the quarter ending December 12, 2018 was $528m a 27.65% increase of 146m year over year
View Chart On Koyfin

Quarterly INCY EBITDA Data

12/2018$103m
09/2018$49m
06/2018$104m
03/2018$-47m
12/2017$-110m
09/2017$22m
06/2017$26m
03/2017$-116m
12/2016$60m
09/2016$39m

Annual INCY EBITDA Data

2018$209m
2017$-178m
2016$191m
2015$62m
2014$1m
2013$-11m
2012$4m
2011$-140m
2010$36m
2009$-121m